Endocrine Diseases
8
3
4
1
Key Insights
Highlights
Success Rate
50% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 85/100
12.5%
1 terminated out of 8 trials
50.0%
-36.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 1 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (8)
Diagnosis of Pheochromocytoma
Evaluation of Adults With Endocrine and Metabolic-Related Conditions
Evaluation of Children With Endocrine and Metabolic-Related Conditions
Spatiotemporal Dynamics and Prognostic Value of the 18F-FDG PET Neuro-Metabolic Network
Functional Status in Hospitalized Endocrine Disorders
Performance of the Diagnostic Value of Bone Age Assessment Software Based on Deep Learning in Chinese Children
Endocrine Studies in Health and Disease
Male:Female Birth Ratios and Phthalate Levels